â??A Prospective, Open label, Randomized-controlled study to evaluate the efficacy and safety of Amrta Karuna Syrup in mildly symptomatic COVID- 19 patientsâ??

Vopec Pharmaceuticals Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Subjects age group 18 - 65 years both gender
•2.Patients diagnosed with COVID-19 positive mild symptomatic patients (Confirmed by RTPCR) - Patients with uncomplicated upper respiratory infection
•a.Spo2 >94% in room air
•b.Respiratory rate <24 per min
•c.No evidence of hypoxaemia or
•breathlessness
•3.Subjects willing to give a written informed consent and come for a regular follow up
•4.Subject willing to abide by and comply with the study protocol

•i.Presence of acute hypoxic respiratory failure.
•ii.Intensive care unit (ICU) stay.
•iii. Patients who need mechanical ventilation.
•iv.Category 6 or 5 based on modified 7-category ordinal scale of clinical status

发起方